Experimental gene-silencing therapy offers hope for hepatitis B cure

Chronic hepatitis B is a long-lasting condition caused by the hepatitis B virus (HBV) that affects about 240 million people worldwide. Most people infected show no symptoms for years, but when symptoms do appear, they can include fatigue, jaundice and abdominal pain. Current antiviral treatments are designed to keep the virus under control, but they are not a cure, and medications are usually taken indefinitely.

Read it at Medical Xpress ↗

← Front page